Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients

1. Vicente-Valor, J.
2. Escudero-Vilaplana, V.
3. Collado-Borrell, R.
4. López-López, C.
5. Villanueva-Bueno, C.
6. Revuelta-Herrero, J.L.
7. Ruiz-Briones, P.
8. Somoza-Fernández, B.
9. Herranz, A.
10. Sanjurjo, M.